Therapeutic effect of ultra-long-lasting human C-peptide delivery against hyperglycemia-induced neovascularization in diabetic retinopathy
Theranostics · 2023
DOI: 10.7150/thno.81714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Chan-Hee Moon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biochemistry, Kangwon National University School of Medicine, Chuncheon, Kangwon-do 24341, Korea. Hauptthemen laut MEDLINE: Retinal Neovascularization, Diabetic Retinopathy, Hyperglycemia, Diabetes Mellitus. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biochemistry, Kangwon National University School of Medicine, Chuncheon, Kangwon-do 24341, Korea.
Zitieren
APA
Moon, C. H., Lee, A. J., Jeon, H. Y., Kim, E. B., & Ha, K. S. (2023). Therapeutic effect of ultra-long-lasting human C-peptide delivery against hyperglycemia-induced neovascularization in diabetic retinopathy. Theranostics. https://doi.org/10.7150/thno.81714
Vancouver
Moon CH, Lee AJ, Jeon HY, Kim EB, Ha KS. Therapeutic effect of ultra-long-lasting human C-peptide delivery against hyperglycemia-induced neovascularization in diabetic retinopathy. Theranostics. 2023. doi:10.7150/thno.81714
BibTeX
@article{Moon2023,
author = {Moon, Chan-Hee and Lee, Ah-Jun and Jeon, Hye-Yoon and Kim, Eun-Bin and Ha, Kwon-Soo},
title = {Therapeutic effect of ultra-long-lasting human C-peptide delivery against hyperglycemia-induced neovascularization in diabetic retinopathy},
journal = {Theranostics},
year = {2023},
doi = {10.7150/thno.81714}
}
EUVIMED